Sorry, you need to enable JavaScript to visit this website.

A Study to Learn How Different Products of the Study Medicine Called Osivelotor Are Taken up Into the Blood in Healthy Adults

A Phase 1, Open-Label, Randomized, Single-Dose, Parallel Design Study to Evaluate Pharmacokinetic Comparability of Two PF-07940367 Film-Coated Tablet Formulations Administered as 150 mg Under Fasted Conditions in Healthy Participants

Category & Conditions: Immune System Diseases and Conditions
Medicine: OSIVELOTOR
ClinicalTrials.gov Identifier (NCT): NCT06190561
Protocol ID: C5351008
Report Type: Final
Language: English

Open Plain Language Summary Result:

Click here